You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II (MP32)1 Sep 2021MP32-10 RACIAL DIFFERENCES IN THE TREATMENT AND OUTCOMES FOR PROSTATE CANCER IN MASSACHUSETTS Alexander Putnam Cole, Peter Herzog, Hari S lyer, Maya Marchese, Logan Briggs, Khalid Alkhatib, Brandon A Mahal, Stuart Lipsitz, Joshua Nyambose, Susan Gershman, Mark Kennedy, Gail Merriam, Timothy R Rebbeck, and Quoc-Dien Trinh Alexander Putnam ColeAlexander Putnam Cole More articles by this author , Peter HerzogPeter Herzog More articles by this author , Hari S lyerHari S lyer More articles by this author , Maya MarcheseMaya Marchese More articles by this author , Logan BriggsLogan Briggs More articles by this author , Khalid AlkhatibKhalid Alkhatib More articles by this author , Brandon A MahalBrandon A Mahal More articles by this author , Stuart LipsitzStuart Lipsitz More articles by this author , Joshua NyamboseJoshua Nyambose More articles by this author , Susan GershmanSusan Gershman More articles by this author , Mark KennedyMark Kennedy More articles by this author , Gail MerriamGail Merriam More articles by this author , Timothy R RebbeckTimothy R Rebbeck More articles by this author , and Quoc-Dien TrinhQuoc-Dien Trinh More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002036.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Massachusetts (MA) is a northeastern state with universally mandated health insurance since 2006. Although Black men have generally worse prostate cancer outcomes, emerging data suggest they may experience equivalent outcomes within a fully insured system. In this setting, we analyzed treatment and outcomes of White and Black non-Hispanic men in MA. METHODS: White and Black men 20 and older diagnosed with localized intermediate- and high-risk non-metastatic prostate cancer 2004-2015 were identified in the MA Cancer Registry. Adjusted logistic regression models were used to assess predictors of definitive therapy and geographic variation in receipt of definitive therapy was compared between MA counties. Adjusted and unadjusted survival models compared cancer specific mortality. Interaction terms were used to assess whether the effect of race varied between counties. RESULTS: A total of 20856 men were identified. Of these, 19287 (92.5%) were White. There were significant county-level differences in odds of receiving definitive therapy and survival (Figure 1). Survival was worse in high-risk cancer (aHR 1.50 95% CI 1.4 - 1.60) and in those with public insurance (aHR, Medicaid and Medicare 1.69 95% CI 1.38-2.07 and 1.2 95% CI 1.14-1.35, respectively). Black men were less likely to receive definitive therapy (aOR 0.78, 95% CI: 0.74, 0.83) but had improved overall survival at 5 and 10 years on an unadjusted survival analysis (Figure 2) and a 17% lower cancer-specific mortality (aHR 0.83 95% CI 0.7-0.99). CONCLUSIONS: Despite lower odds of definitive treatment, Black men experience decreased cancer specific mortality compared to White men in MA. These data support the growing body of research showing that Black men may achieve equivalent or even better outcomes than White men within the context of a well-insured population. Source of Funding: none © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e568-e569 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alexander Putnam Cole More articles by this author Peter Herzog More articles by this author Hari S lyer More articles by this author Maya Marchese More articles by this author Logan Briggs More articles by this author Khalid Alkhatib More articles by this author Brandon A Mahal More articles by this author Stuart Lipsitz More articles by this author Joshua Nyambose More articles by this author Susan Gershman More articles by this author Mark Kennedy More articles by this author Gail Merriam More articles by this author Timothy R Rebbeck More articles by this author Quoc-Dien Trinh More articles by this author Expand All Advertisement Loading ...